We also observed a network of female-biased genes enriched on estrogenic, progestogenic, androgenic, and aromatase inhibitor drugs, corroborating these genes interact with sex hormone biology in women, yet the use of estrogen therapies for AD in women remains uncertain2,15. Here, CYP19A1 is linked to Alzheimer disease.